Janus Henderson Group PLC trimmed its position in shares of Centene Co. (NYSE:CNC – Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 785,360 shares of the company’s stock after selling 86,712 shares during the quarter. Janus Henderson Group PLC’s holdings in Centene were worth $47,577,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the company. Capital Advisors Ltd. LLC boosted its stake in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares during the period. Hurley Capital LLC purchased a new position in shares of Centene during the fourth quarter valued at approximately $26,000. Rialto Wealth Management LLC bought a new position in shares of Centene during the fourth quarter valued at approximately $30,000. OFI Invest Asset Management purchased a new stake in shares of Centene in the fourth quarter worth approximately $33,000. Finally, SRS Capital Advisors Inc. lifted its stake in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after acquiring an additional 267 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Trading Down 6.1%
Shares of NYSE:CNC opened at $59.02 on Wednesday. The company has a market capitalization of $29.37 billion, a PE ratio of 9.46, a P/E/G ratio of 0.80 and a beta of 0.48. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. Centene Co. has a 12-month low of $55.03 and a 12-month high of $80.59. The business’s fifty day simple moving average is $60.59 and its 200-day simple moving average is $60.47.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. Robert W. Baird reduced their target price on Centene from $71.00 to $69.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 15th. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, April 28th. Barclays lowered their price objective on shares of Centene from $93.00 to $84.00 and set an “overweight” rating for the company in a research report on Monday, April 28th. Jefferies Financial Group reduced their target price on shares of Centene from $64.00 to $61.00 and set a “hold” rating on the stock in a research report on Tuesday, April 29th. Finally, Guggenheim reiterated a “neutral” rating on shares of Centene in a report on Tuesday, April 29th. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and an average price target of $79.77.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories
- Five stocks we like better than Centene
- Airline Stocks – Top Airline Stocks to Buy Now
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Breakout Stocks: What They Are and How to Identify Them
- Why Boeing May Be Ready to Take Off After Latest Developments
- Options Trading – Understanding Strike Price
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.